selected publications
-
academic article
- Mitochondrial haplogroups and cognitive progression in Parkinson's disease.. Brain : a journal of neurology. 146:42-49. 2023
- Joint Modeling Study Identifies Blood-Based Transcripts Link to Cognitive Decline in Parkinson's Disease.. Movement disorders : official journal of the Movement Disorder Society. 37:2386-2395. 2022
- Glucosylceramide in cerebrospinal fluid of patients with GBA-associated and idiopathic Parkinson's disease enrolled in PPMI.. NPJ Parkinson's disease. 7:-. 2021
- Genome-wide survival study identifies a novel synaptic locus and polygenic score for cognitive progression in Parkinson's disease.. Nature genetics. 53:787-793. 2021
- GBA. Neurology. 95:e685-e696. 2020
- Publisher Correction: Enhancers active in dopamine neurons are a primary link between genetic variation and neuropsychiatric disease.. Nature neuroscience. 22:144-147. 2019
- Enhancers active in dopamine neurons are a primary link between genetic variation and neuropsychiatric disease.. Nature neuroscience. 21:1482-1492. 2018
- Prediction of cognition in Parkinson's disease with a clinical-genetic score: a longitudinal analysis of nine cohorts.. The Lancet. Neurology. 16:620-629. 2017
- Specifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's.. Annals of neurology. 80:674-685. 2016
- Association between α-synuclein blood transcripts and early, neuroimaging-supported Parkinson's disease.. Brain : a journal of neurology. 138:2659-71. 2015